Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight

NAActive, not recruitingINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

November 8, 2018

Primary Completion Date

November 30, 2021

Study Completion Date

April 30, 2022

Conditions
EfficacySafety Issues
Interventions
COMBINATION_PRODUCT

AMIA with SHARESOURCE Connectivity Platform

The investigators will conduct a randomized, cross-over study in peritoneal dialysis patients in which patients are randomized to either Home Choice Pro (which remains the most widely used Baxter cycler) versus treatment with the Baxter AMIA automated peritoneal dialysis system with SHARESOURCE connectivity.

DEVICE

HomeChoice PRO

Usual care

Trial Locations (2)

91915

Home Dialysis Therapies of San Diego, Chula Vista

92131

Home Dialysis Therapies of San Diego, San Diego

All Listed Sponsors
collaborator

Baxter Healthcare Corporation

INDUSTRY

collaborator

Scripps Health

OTHER

collaborator

Home Dialysis Therapies of San Diego

UNKNOWN

lead

University of California, San Diego

OTHER

NCT04002440 - Directed Use of REmote Patient Management System AMia to Achieve Prescribed Dry Weight | Biotech Hunter | Biotech Hunter